INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 196 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $493,000 | -67.7% | 7,830 | -36.5% | 0.05% | -43.2% |
| Q4 2019 | $1,528,000 | -21.6% | 12,329 | -58.0% | 0.09% | -5.4% |
| Q3 2019 | $1,948,000 | -16.8% | 29,354 | -0.2% | 0.09% | -10.6% |
| Q2 2019 | $2,340,000 | -4.3% | 29,409 | +34.5% | 0.10% | +10.6% |
| Q1 2019 | $2,446,000 | +171.8% | 21,870 | +144.9% | 0.09% | +161.1% |
| Q4 2018 | $900,000 | +318.6% | 8,930 | +425.3% | 0.04% | +500.0% |
| Q3 2018 | $215,000 | – | 1,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |